Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Help & FAQ
Home
Profiles
Research units
Core Facilities
Publications
Search by expertise, name or affiliation
Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
CNTO1959PSA2001 Study Group
Arthritis and Rheumatic Diseases
Research output
:
Contribution to journal
›
Article
›
peer-review
153
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
guselkumab
100%
Psoriatic Arthritis
64%
Placebos
36%
Safety
31%
Ustekinumab
6%
Psoriasis
6%
Rheumatology
5%
Joints
4%
Signs and Symptoms
4%
Interleukin-23 Subunit p19
3%
Therapeutics
3%
Romania
3%
Computer Systems
2%
Russia
2%
Injections
2%
Body Surface Area
2%
Poland
2%
Interleukins
2%
Dermatology
2%
Spain
2%
Intention
2%
Canada
2%
Germany
2%
Comorbidity
1%
Monoclonal Antibodies
1%
Tumor Necrosis Factor-alpha
1%
Research Personnel
1%
Databases
1%
Antibodies
1%
Infections
1%
Pharmaceutical Preparations
0%
Population
0%